of delivery of medication therapy man-
agement services. 
‘‘(II) 
INDIVIDUALIZED.—Such 
services shall be patient-specific and 
individualized and shall be provided 
directly to the patient by a pharmacist 
or other health care provider with ad-
vanced training in medication man-
agement. 
‘‘(III) DISTINCT
FROM
OTHER 
ACTIVITIES.—Such services shall be 
distinct from any activities related to 
formulary development and use, gen-
eralized patient education and infor-
mation activities, and any population- 
focused quality assurance measures 
for medication use. 
‘‘(iii) OPPORTUNITY TO IDENTIFY PA-
TIENTS IN NEED OF MEDICATION THERAPY 
MANAGEMENT
SERVICES.—The program 
shall provide opportunities for health care 
providers to identify patients who should 
receive medication therapy management 
services.’’; 
VerDate Aug 31 2005 
00:36 May 02, 2006
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H5182.IH
H5182
ccoleman on PROD1PC71 with BILLS
(C) by striking subparagraph (E) and in-
serting the following: 
‘‘(E) PHARMACY FEES.— 
‘‘(i) IN GENERAL.—The PDP sponsor 
of a prescription drug plan shall pay phar-
macists and others providing services 
under the medication therapy management 
program under this paragraph based on 
the time and intensity of services provided 
to enrollees. 
‘‘(ii) SUBMISSION ALONG WITH PLAN 
INFORMATION.—Each such sponsor shall 
disclose to the Secretary upon request the 
amount of any such payments and shall 
submit a description of how such payments 
are calculated along with the information 
submitted under section 1860D–11(b). 
Such description shall be submitted at the 
same time and in a similar manner to the 
manner in which the information described 
in paragraph (2) of such section is sub-
mitted.’’; and 
(D) by adding at the end the following new 
subparagraph: 
VerDate Aug 31 2005 
00:36 May 02, 2006
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H5182.IH
H5182
ccoleman on PROD1PC71 with BILLS
‘‘(F) 
PHARMACY
ACCESS
REQUIRE-
MENTS.—The PDP sponsor of a prescription 
drug plan shall secure the participation in its 
network of a sufficient number of retail phar-
macies to assure that enrollees have the option 
of obtaining services under the medication ther-
apy management program under this paragraph 
directly from community-based retail phar-
macies.’’. 
(2) EFFECTIVE DATE.—The amendments made 
by this subsection shall apply to medication therapy 
management services provided on or after January 
1, 2008. 
(b) MEDICATION
THERAPY
MANAGEMENT
DEM-
ONSTRATION PROGRAM.—Section 1860D–4(c) of the So-
cial Security Act (42 U.S.C.1395w–104(c)) is amended by 
adding at the end the following new paragraph: 
‘‘(3) COMMUNITY-BASED MEDICATION THERAPY 
MANAGEMENT DEMONSTRATION PROGRAM.— 
‘‘(A) ESTABLISHMENT.— 
‘‘(i) IN GENERAL.—By not later than 
January 1, 2008, the Secretary shall es-
tablish a 2-year demonstration program, 
based on the recommendations of the Best 
Practices Commission established under 
VerDate Aug 31 2005 
00:36 May 02, 2006
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H5182.IH
H5182
ccoleman on PROD1PC71 with BILLS
subparagraph (B), with both PDP spon-
sors of prescription drug plans and Medi-
care Advantage Organizations offering 
MA–PD plans, to examine the impact of 
medication therapy management furnished 
by a pharmacist in a community-based or 
ambulatory-based setting on quality of 
care, spending under this part, and patient 
health. 
‘‘(ii) SITES.— 
‘‘(I) IN
GENERAL.—Subject to 
subclause (II), the Secretary shall 
designate not less than 10 PDP spon-
sors of prescription drug plans or 
Medicare Advantage organizations of-
fering MA–PD plans, none of which 
provide prescription drug coverage 
under such plans in the same PDP or 
MA region, respectively, to conduct 
the demonstration program under this 
paragraph. 
‘‘(II) DESIGNATION CONSISTENT 
WITH
RECOMMENDATIONS
OF
BEST 
PRACTICES
COMMISSION.—The Sec-
retary shall ensure that the designa-
VerDate Aug 31 2005 
00:36 May 02, 2006
Jkt 049200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5182.IH
H5182
ccoleman on PROD1PC71 with BILLS